CatalystTech/AI
THE STARTUP USING AI TO HELP RARE DISEASE FAMILIES DEVELOP CUSTOM TREATMENTS - CNBC
AI-driven custom treatments offer rare disease families a novel, targeted therapeutic pathway.
What changed
AI-driven custom treatments offer rare disease families a novel, targeted therapeutic pathway.
Why it matters
AI-driven custom treatments offer rare disease families a novel, targeted therapeutic pathway. — impact context not separately stored; see What changed.
← Dashboard
Aug 18, 2026 01:02 PM ET